SU5416 [204005-46-9]

AbMole BioScience

SU5416 [204005-46-9]

7

204005-46-9

Research Use Only

99.81%

C15H14N2O

238.28

Semaxinib (SU5416) is a novel small molecule multi-targeted kinase inhibitor of VEGF receptors, c-kit and FLT3. Semaxinib reversibly inhibits ATP binding to the tyrosine kinase domain of VEGFR2, potentially inhibiting VEGF-stimulated endothelial cell migration and proliferation, thereby reducing tumor microvasculature.

CC1=CC(=C([NH]1)/C=C/2C(=O)NC3=CC=CC=C23)C

-20°C

12161500